Detalles de la búsqueda
1.
First clinical evaluation of the safety and efficacy of tarumase for the debridement of venous leg ulcers.
Int Wound J
; 21(3): e14805, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385795
2.
A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
Int Wound J
; 21(4): e14882, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38606794
3.
A single arm prospective feasibility study evaluating wound closure with a unique wearable device that provides intermittent plantar compression and offloading in the treatment of non-healing diabetic foot ulcers.
Int Wound J
; 20(3): 853-860, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054243
4.
A multicenter, randomized controlled clinical trial evaluating the effects of a novel autologous heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Final analysis.
Int Wound J
; 20(10): 4083-4096, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37402533
5.
Wound repair, safety, and functional outcomes in reconstructive lower extremity foot and ankle surgery using a dehydrated amnion/chorion allograft membrane.
Int Wound J
; 19(8): 2062-2070, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373506
6.
A multi-centre, single-blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers.
Int Wound J
; 19(4): 791-801, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34418302
7.
Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial.
Int Wound J
; 19(5): 1197-1209, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35001559
8.
Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi-centre clinical trial with a microvascular tissue allograft.
Int Wound J
; 19(4): 811-825, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34469077
9.
A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis.
Int Wound J
; 19(1): 64-75, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33942506
10.
Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers.
Int Wound J
; 19(4): 932-944, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35080127
11.
An observational pilot study using a purified reconstituted bilayer matrix to treat non-healing diabetic foot ulcers.
Int Wound J
; 17(4): 966-973, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32266774
12.
Complete wound closure following a single topical application of a novel autologous homologous skin construct: first evaluation in an open-label, single-arm feasibility study in diabetic foot ulcers.
Int Wound J
; 17(5): 1366-1375, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32453512
13.
Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
Int Wound J
; 15(6): 950-957, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30019528
14.
An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
Int Wound J
; 15(5): 731-739, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29682897
15.
A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
Int Wound J
; 14(2): 307-315, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27073000
16.
Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.
Int Wound J
; 13(2): 272-82, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26695998
17.
A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers.
Int Wound J
; 12(6): 724-32, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424146
18.
A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers.
Int Wound J
; 11(2): 122-8, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24618401
19.
Prospective, randomized, blinded, comparative study of injectable micronized dehydrated amniotic/chorionic membrane allograft for plantar fasciitis--a feasibility study.
Foot Ankle Int
; 34(10): 1332-9, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23945520
20.
A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers.
Int Wound J
; 10(5): 502-7, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23742102